Jens M Hohlfeld Selected Research

Fluticasone (Cutivate)

4/2020

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens M Hohlfeld Research Topics

Disease

34	Asthma (Bronchial Asthma) 01/2023 - 01/2002
31	Inflammation (Inflammations) 01/2024 - 01/2002
21	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 03/2010
9	Allergic Rhinitis 09/2023 - 09/2012
8	Pneumonia (Pneumonitis) 10/2023 - 10/2004
8	Hypersensitivity (Allergy) 01/2023 - 06/2010
5	Seasonal Allergic Rhinitis (Hay Fever) 01/2023 - 10/2011
4	Eosinophilia 01/2018 - 09/2004
4	Reperfusion Injury 09/2005 - 06/2002
3	Infections 01/2024 - 06/2010
3	Lung Diseases (Lung Disease) 11/2023 - 01/2012
3	Body Weight (Weight, Body) 10/2023 - 05/2003
3	Emphysema 01/2021 - 06/2008
3	Surfactant Dysfunction 09/2005 - 03/2004
2	Hypoxia (Hypoxemia) 01/2022 - 12/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2021
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021 - 01/2012
2	Respiratory Hypersensitivity 05/2015 - 04/2014
2	Airway Obstruction (Choking) 02/2015 - 03/2011
2	Disease Progression 01/2012 - 03/2011
2	Hyperplasia 08/2007 - 05/2003
2	Ischemia 08/2007 - 01/2002
1	Treatment-Resistant Depressive Disorder 01/2023
1	Hypothermia 01/2023
1	Rhinitis 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Dyspnea (Shortness of Breath) 04/2022
1	Pulmonary Edema 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020

Drug/Important Bio-Agent (IBA)

24	AllergensIBA 01/2023 - 10/2002
13	Surface-Active Agents (Surfactants)IBA 11/2023 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2011
6	indacaterolIBA 04/2022 - 01/2018
6	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2022 - 01/2018
5	LipopolysaccharidesIBA 01/2024 - 01/2012
5	EndotoxinsIBA 10/2023 - 06/2008
5	GoldIBA 02/2015 - 01/2012
5	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 04/2014 - 04/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 01/2021
4	CytokinesIBA 01/2022 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 09/2005
4	PotassiumIBA 09/2005 - 06/2002
3	salicylhydroxamic acid (SHAM)IBA 01/2023 - 06/2003
3	Bronchodilator Agents (Bronchodilators)IBA 04/2022 - 01/2018
3	Volatile Organic CompoundsIBA 01/2022 - 09/2011
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	Immunoglobulin E (IgE)IBA 01/2021 - 10/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2005
3	Catalytic DNA (Deoxyribozyme)IBA 01/2018 - 09/2015
3	Methacholine Chloride (Methacholine)FDA Link 05/2015 - 11/2005
3	Interleukin-5 (Interleukin 5)IBA 05/2015 - 04/2011
3	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2013 - 03/2004
2	AerosolsIBA 01/2024 - 01/2024
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2023 - 05/2003
2	Nasal Decongestants (Decongestants)IBA 09/2023 - 01/2023
2	EsketamineIBA 09/2023 - 01/2023
2	Iron-Dextran Complex (InFed)FDA Link 01/2023 - 01/2018
2	LipidsIBA 01/2023 - 01/2020
2	EnzymesIBA 12/2021 - 06/2010
2	prostaglandin D2 receptorIBA 10/2021 - 02/2014
2	Acetates (Acetic Acid Esters)FDA Link 04/2021 - 01/2021
2	Muscarinic AntagonistsIBA 04/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2019
2	Arginine (L-Arginine)FDA Link 01/2020 - 06/2010
2	Therapeutic UsesIBA 01/2017 - 03/2009
2	Messenger RNA (mRNA)IBA 09/2015 - 03/2014
2	von Willebrand FactorIBA 01/2015 - 03/2014
2	OzoneIBA 09/2011 - 04/2011
2	poractant alfa (Curosurf)FDA Link 01/2009 - 03/2004
2	Dextrans (Dextran)FDA Link 09/2005 - 01/2005
2	CelsiorIBA 07/2004 - 06/2002
1	BradykininIBA 10/2023
1	Nasal SpraysIBA 01/2023
1	Oxymetazoline FDA Link 01/2023
1	Immunoglobulin FragmentsIBA 01/2023
1	Hypromellose DerivativesIBA 01/2023
1	signal peptide receptorIBA 01/2022
1	AldehydesIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 12/2021
1	Prostaglandin D2IBA 10/2021
1	Monoclonal AntibodiesIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 12/2020
1	tiotropium-olodaterolIBA 12/2020
1	GSK2798745IBA 10/2020
1	CationsIBA 10/2020
1	Salmeterol Xinafoate (Serevent)FDA Link 04/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 04/2020
1	Amino Acids FDA Link 01/2020
1	GSK2245035IBA 01/2020
1	NitrogenIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020

Therapy/Procedure

6	Therapeutics 04/2022 - 01/2009
3	Lung Transplantation 09/2005 - 01/2002
1	Nebulizers and Vaporizers (Inhaler) 01/2024
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2024
1	Dry Powder Inhalers 01/2024